BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies EBIT

EBIT (Earnings Before Interest and Taxes) analysis for IPA.

Quarterly EBIT

-$3.61M
↑ 85.17% YoY

As of Jan 31, 2026

Annual EBIT (TTM)

-$12.47M
↑ 65.05% YoY

Trailing 12 months ending Jan 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin